Related Experiment Video
Updated: Jun 3, 2026
08:09
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
Gene-environmental interactions: Lessons from porphyria
1Laboratory of Biochemical Hematology, The Rockefeller University, New York, U.S.A., sassas@yamanouchi.co.jp.
Environmental Health and Preventive Medicine
|March 25, 2011
Summary
Porphyrias are rare metabolic disorders affecting heme production, leading to skin and nerve issues. Genetic and environmental factors influence disease severity and expression.
Area of Science:
- Biochemistry
- Genetics
- Metabolic Disorders
Background:
- Porphyrias are uncommon metabolic conditions stemming from enzyme deficiencies in heme biosynthesis.
- Key symptoms include cutaneous photosensitivity and neurologic disturbances.
- These disorders present with genetic heterogeneity, involving multiple mutations.
Purpose of the Study:
- To elucidate the complex nature of porphyrias.
- To understand the interplay between genetic defects and environmental factors in disease manifestation.
- To highlight the clinical relevance of studying acute hepatic porphyrias.
Main Methods:
- Molecular analysis of gene defects.
- Examination of enzyme activities in the heme biosynthetic pathway.
- Review of clinical cases and genetic data.
Main Results:
- Identified multiple and heterogeneous mutations in porphyria genes.
- Demonstrated that not all gene carriers develop clinical disease.
- Highlighted the significant role of acquired and environmental factors in disease expression.
Conclusions:
- Porphyrias are complex metabolic disorders with variable clinical presentations.
- Genetic polymorphisms may influence porphyria response to environmental factors.
- Understanding these factors is crucial for managing patients with porphyria.
Related Concept Videos
01:20Gene-Environment Interactions
Gene expression is a dynamic process that is significantly influenced by environmental factors. This interaction underlies the complex nature of biological development and the phenotypic differences observed among individuals, even among those with identical genetic makeups. Factors such as radiation, temperature, behavior, nutrition, and stress play pivotal roles in determining how genes are expressed. The concept of the reaction range is central to understanding this interaction. It posits...
02:27Background and Environment Affect Phenotype
Although the genetic makeup of an organism plays a major role in determining the phenotype, there are also several environmental factors, such as temperature, oxygen availability, presence of mutagens, that can alter an organism’s phenotype.
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...